Acute Myeloid Leukemia and the Role of FLT3 Inhibitors: Best Practices for the Interprofessional Care Team

What's new in FLT3 acute myeloid leukemia (AML)? Join to hear a panel of experts discuss how they use FLT3 inhibitors in patients with AML.

Credit available for this activity expires: 1/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987563?ecd=bdc_podcast_libsyn_mscpedu